Literature DB >> 25268038

DNA polymerase η is regulated by poly(rC)-binding protein 1 via mRNA stability.

Cong Ren1, Seong-Jun Cho1, Yong-Sam Jung1, Xinbin Chen1.   

Abstract

POLH (DNA polymerase η), a target of p53 tumour suppressor, plays a key role in TLS (translesion DNA synthesis). Loss of POLH is responsible for the human cancer-prone syndrome XPV (xeroderma pigmentosum variant). Owing to its critical role in DNA repair and genome stability, POLH expression and activity are regulated by multiple pathways. In the present study, we found that the levels of both POLH transcript and protein were decreased upon knockdown of the transcript encoding PCBP1 [poly(rC)-binding protein 1]. We also found that the half-life of POLH mRNA was markedly decreased upon knockdown of PCBP1. Moreover, we found that PCBP1 directly bound to the POLH 3'-UTR and the PCBP1-binding site in POLH mRNA is an atypical AU-rich element. Finally, we showed that the AU-rich element in POLH 3'-UTR was responsive to PCBP1 and sufficient for PCBP1 to regulate POLH expression. Taken together, we uncovered a novel mechanism by which POLH expression is controlled by PCBP1 via mRNA stability.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25268038      PMCID: PMC4562393          DOI: 10.1042/BJ20141164

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

1.  DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes.

Authors:  X Zeng; D B Winter; C Kasmer; K H Kraemer; A R Lehmann; P J Gearhart
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

2.  Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage.

Authors:  Patricia L Kannouche; Jonathan Wing; Alan R Lehmann
Journal:  Mol Cell       Date:  2004-05-21       Impact factor: 17.970

3.  Down-regulation of poly(rC)-binding protein 1 correlates with the malignant transformation of hydatidiform moles.

Authors:  Zhonghua Shi; Ting Zhang; Wei Long; Xin Wang; Xiang Zhang; Xiufeng Ling; Hongjuan Ding
Journal:  Int J Gynecol Cancer       Date:  2012-09       Impact factor: 3.437

4.  Structural and functional analysis of an mRNP complex that mediates the high stability of human beta-globin mRNA.

Authors:  J Yu; J E Russell
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

5.  RNA-binding proteins heterogeneous nuclear ribonucleoprotein A1, E1, and K are involved in post-transcriptional control of collagen I and III synthesis.

Authors:  Bernd-Joachim Thiele; Anke Doller; Thilo Kähne; Reinhard Pregla; Roland Hetzer; Vera Regitz-Zagrosek
Journal:  Circ Res       Date:  2004-10-28       Impact factor: 17.367

6.  Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.

Authors:  Yong-Sam Jung; Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2009-12-14       Impact factor: 4.272

7.  Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer.

Authors:  M R Pillai; P Chacko; L A Kesari; P G Jayaprakash; H N Jayaram; A C Antony
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

8.  Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk.

Authors:  Julie Di Lucca; Mickael Guedj; Jean-Jacques Lacapère; Maria Concetta Fargnoli; Agnes Bourillon; Philippe Dieudé; Nicolas Dupin; Pierre Wolkenstein; Philippe Aegerter; Philippe Saiag; Vincent Descamps; Celeste Lebbe; Nicole Basset-Seguin; Ketty Peris; Bernard Grandchamp; Nadem Soufir
Journal:  Eur J Cancer       Date:  2009-05-26       Impact factor: 9.162

9.  8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins.

Authors:  Giovanni Maga; Giuseppe Villani; Emmanuele Crespan; Ursula Wimmer; Elena Ferrari; Barbara Bertocci; Ulrich Hübscher
Journal:  Nature       Date:  2007-05-16       Impact factor: 49.962

10.  DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse.

Authors:  Frédéric Delbos; Said Aoufouchi; Ahmad Faili; Jean-Claude Weill; Claude-Agnès Reynaud
Journal:  J Exp Med       Date:  2006-12-26       Impact factor: 14.307

View more
  7 in total

1.  RNA-binding Protein PCBP2 Regulates p73 Expression and p73-dependent Antioxidant Defense.

Authors:  Cong Ren; Jin Zhang; Wensheng Yan; Yanhong Zhang; Xinbin Chen
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

2.  A PolH Transcript with a Short 3'UTR Enhances PolH Expression and Mediates Cisplatin Resistance.

Authors:  Jin Zhang; Wenqiang Sun; Cong Ren; Xiangmudong Kong; Wensheng Yan; Xinbin Chen
Journal:  Cancer Res       Date:  2019-05-07       Impact factor: 12.701

Review 3.  Maintenance of Genome Integrity: How Mammalian Cells Orchestrate Genome Duplication by Coordinating Replicative and Specialized DNA Polymerases.

Authors:  Ryan Barnes; Kristin Eckert
Journal:  Genes (Basel)       Date:  2017-01-06       Impact factor: 4.096

4.  The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin.

Authors:  Yujia Zheng; Zheng Zhou; Ran Wei; Chu Xiao; Hao Zhang; Tao Fan; Bo Zheng; Chunxiang Li; Jie He
Journal:  J Transl Med       Date:  2022-07-30       Impact factor: 8.440

Review 5.  Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer.

Authors:  Wencheng Kong; Guang Yin; Sixin Zheng; Xinchun Liu; Akao Zhu; Panpan Yu; Jian Zhang; Yuqiang Shan; Rongchao Ying; Huicheng Jin
Journal:  Genes Dis       Date:  2021-08-21

Review 6.  The hnRNP family: insights into their role in health and disease.

Authors:  Thomas Geuens; Delphine Bouhy; Vincent Timmerman
Journal:  Hum Genet       Date:  2016-05-23       Impact factor: 4.132

7.  PCBP1 depletion promotes tumorigenesis through attenuation of p27Kip1 mRNA stability and translation.

Authors:  Hongshun Shi; Hui Li; Ronghua Yuan; Wen Guan; Xiaomei Zhang; Shaoyang Zhang; Wenliang Zhang; Fang Tong; Li Li; Zhihong Song; Changwei Wang; Shulan Yang; Haihe Wang
Journal:  J Exp Clin Cancer Res       Date:  2018-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.